Re: Month 10

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2647 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Month 10

in response to

Month 10

SanFrancisco99

posted on Apr 15, 2017 03:16PM

All this quiet time with Zenith is making me think that something very significant is being negotiated and that possibly a deal is in the works , Not sure how fair it would be to a possible acquiring company for Zenith to announce good results in phase 1 when you finalizing a deal, being a private company Zentih has more leeway in when and how they announce any news

6 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply